Session

Treating urological cancers: New twists and turns in the road

Industry session by IPSEN PHARMA

  • Location:
    Room Stockholm, North Hall (Level 1)
  • Chair:
     N. James, Birmingham (GB)
  • Aims and objectives of this session

    • Give an overview of the progress in prostate cancer diagnosis and management to date, with a focus on potential future advances in hormone manipulation in the field

    • Provide an update on the recent changes in the RCC treatment landscape from the adjuvant to first- and second-line settings

    • Educate attendees on the role of enhanced visualisation techniques in bladder cancer in terms of diagnosis and staging, as well as the resulting clinical outcomes.

Welcome and introduction
 N. James, Birmingham (GB)
How far have we improved on prostate cancer management?
 T. Lynch, Dublin (IE)
Systemic therapy in RCC – Current landscape and future directions
 S. Osanto, Leiden (NL)
The future of non-muscle-invasive bladder cancer management
 S. Shariat, Vienna (AT)
Questions and answers
 
 N. James, Birmingham (GB)
 
 T. Lynch, Dublin (IE)
 
 S. Osanto, Leiden (NL)
 
 S. Shariat, Vienna (AT)